Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001167966-05-001151
Filing Date
2005-08-12
Accepted
2005-08-12 16:06:26
Documents
11
Period of Report
2005-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t7177_10q.htm 10-Q 822872
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 63989
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 93540
4 EXHIBIT 10.3 ex10-3.htm EX-10.3 78696
5 EXHIBIT 10.4 ex10-4.htm EX-10.4 100229
6 EXHIBIT 10.5 ex10-5.htm EX-10.5 265721
7 EXHIBIT 10.6 ex10-6.htm EX-10.6 51009
8 EXHIBIT 31.1 ex31-1.htm EX-31.1 18581
9 EXHIBIT 31.2 ex31-2.htm EX-31.2 18183
10 EXHIBIT 32.1 ex32-1.htm EX-32.1 7422
11 EXHIBIT 32.2 ex32-2.htm EX-32.2 7739
  Complete submission text file 0001167966-05-001151.txt   1529500
Mailing Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518
Business Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518 7702710233
THERAGENICS CORP (Filer) CIK: 0000795551 (see all company filings)

EIN.: 581528626 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14339 | Film No.: 051021789
SIC: 3825 Instruments For Meas & Testing of Electricity & Elec Signals